162 related articles for article (PubMed ID: 6109566)
1. Failure of aclacinomycin and 7-con-O-methylnogarol (7-OMEN) to decrease cardiac guanylate cyclase activity.
Levey BA; Ruiz E; Rogerson B; Lehotay DC; Levey GS
Cancer Treat Rep; 1980; 64(10-11):1127-8. PubMed ID: 6109566
[No Abstract] [Full Text] [Related]
2. The effect of vivo doxorubicin (adriamycin) and aclacinomycin administration on guanylate cyclase activity in rat tissue.
Lehotay DC; Levey BA; Rogerson BJ; Levey GS
Proc Soc Exp Biol Med; 1981 Sep; 167(4):459-62. PubMed ID: 6116236
[No Abstract] [Full Text] [Related]
3. Intracellular uptake of 7-con-o-methylnogarol and adriamycin by cells in culture and its relationship to cell survival.
Bhuyan BK; McGovren JP; Crampton SL
Cancer Res; 1981 Mar; 41(3):882-7. PubMed ID: 6450639
[No Abstract] [Full Text] [Related]
4. Cell kill kinetics of several nogalamycin analogs and adriamycin for Chinese hamster ovary, L1210 leukemia, and B16 melanoma cells in culture.
Bhuyan BK; Blowers CL; Crampton SL; Shugars KD
Cancer Res; 1981 Jan; 41(1):18-24. PubMed ID: 7448758
[TBL] [Abstract][Full Text] [Related]
5. Activity of the anthracycline agent, 7-con-O-methylnogarol (7-OMEN), administered orally to mice bearing P388 or L1210 leukemia.
McGovren JP
Cancer Treat Rep; 1980; 64(4-5):727-9. PubMed ID: 6448690
[TBL] [Abstract][Full Text] [Related]
6. Clinical assessment of the structure-activity relationship of anthracyclines and related synthetic derivatives.
Young CW; Raymond V
Cancer Treat Rep; 1986 Jan; 70(1):51-63. PubMed ID: 2935251
[No Abstract] [Full Text] [Related]
7. Inhibition of cardiac guanylate cyclase by doxorubicin and some of its analogs: possible relationship to cardiotoxicity.
Lehotay DC; Levey BA; Rogerson BJ; Levey GS
Cancer Treat Rep; 1982 Feb; 66(2):311-6. PubMed ID: 6120040
[TBL] [Abstract][Full Text] [Related]
8. Cross-resistance of menogaril and mitoxantrone in a subline of P388 leukemia resistant to doxorubicin.
Chandrasekaran B; Dimling J; Capizzi RL
Cancer Treat Rep; 1987 Feb; 71(2):195-6. PubMed ID: 2948640
[TBL] [Abstract][Full Text] [Related]
9. Lethality of nogalamycin, nogalamycin analogs, and adriamycin to cells in different cell cycle phases.
Bhuyan BK; Blowers CL; Shugars KD
Cancer Res; 1980 Oct; 40(10):3437-42. PubMed ID: 7438031
[TBL] [Abstract][Full Text] [Related]
10. The disposition of the new anthracycline antibiotic, menogarol, in mice.
Dodion P; Chang BK; Egorin MJ; Olman EA; Engisch KL; Bachur NR
Drug Metab Dispos; 1984; 12(3):365-70. PubMed ID: 6145565
[TBL] [Abstract][Full Text] [Related]
11. Effect of 7-con-O-methylnogarol on DNA synthesis, survival, and cell cycle progression of Chinese hamster ovary cells.
Adams EG; Crampton SL; Bhuyan BK
Cancer Res; 1981 Dec; 41(12 Pt 1):4981-7. PubMed ID: 6458356
[TBL] [Abstract][Full Text] [Related]
12. Cellular pharmacology of 7(R)-O-methylnogarol: a new anticancer agent.
Egorin MJ; Clawson RE; Cohen JL; Ross LA; Bachur NR
J Pharmacol Exp Ther; 1979 Aug; 210(2):229-36. PubMed ID: 458629
[TBL] [Abstract][Full Text] [Related]
13. Lack of correlation between effects of anthracyclines on in vitro cardiac guanyl cyclase and in vivo cardiotoxicity.
Zbinden G
Cancer Treat Rep; 1982 Aug; 66(8):1677-8. PubMed ID: 6125261
[No Abstract] [Full Text] [Related]
14. Selective inhibition of rat and human cardiac guanylate cyclase in vitro by doxorubicin (adriamycin): possible link to anthracycline cardiotoxicity.
Levey GS; Levey BA; Ruiz E; Lehotay DC
J Mol Cell Cardiol; 1979 Jun; 11(6):591-9. PubMed ID: 37344
[No Abstract] [Full Text] [Related]
15. Effects of 7-R-O-methylnogarol (menogaril) on L1210 cell progression in vitro and in vivo.
Adams EG; Bhuyan BK
Cancer Res; 1986 Dec; 46(12 Pt 1):6125-30. PubMed ID: 2946401
[TBL] [Abstract][Full Text] [Related]
16. Rapid high-performance liquid chromatographic assay for the anthracyclines daunorubicin and 7-con-O-methylnogarol in plasma.
Brown JE; Wilkinson PA; Brown JR
J Chromatogr; 1981 Dec; 226(2):521-5. PubMed ID: 6459335
[No Abstract] [Full Text] [Related]
17. Selective inhibition of rat and human cardiac guanylate cyclase by doxorubicin (adriamycin): possible link to anthracycline cardiotoxicity.
Levey GS; Levey BA; Ruiz E; Lehotay DC
Trans Assoc Am Physicians; 1979; 92():303-8. PubMed ID: 44927
[No Abstract] [Full Text] [Related]
18. Interaction of aclarubicin with DNA as compared with daunorubicin and doxorubicin.
Ando S; Sasada M; Uchino H; Kagawa D; Ueda T; Nakamura T
Nihon Gan Chiryo Gakkai Shi; 1986 Dec; 21(10):2343-55. PubMed ID: 3471823
[No Abstract] [Full Text] [Related]
19. Recent studies on antibiotics and small molecular immunomodulators with potential usefulness in treating lung cancer: Part I - Antitumor antibiotics and their derivatives.
Umezawa H
Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):12-8. PubMed ID: 6173340
[TBL] [Abstract][Full Text] [Related]
20. Menogaril: a new anthracycline agent entering clinical trials.
McGovren JP; Nelson KG; Lassus M; Cradock JC; Plowman J; Christopher JP
Invest New Drugs; 1984; 2(4):359-67. PubMed ID: 6239835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
